Articles |

In Vitro Comparison of Beclomethasone and Salbutamol Metered-Dose Inhaler Aerosols Inhaled During Pediatric Tidal Breathing From Four Valved Holding Chambers FREE TO VIEW

Warren H. Finlay; Peter Zuberbuhler
Author and Funding Information

Affiliations: From the Aerosol Research Laboratory, Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada,  From the Cystic Fibrosis and Pediatric Pulmonary Clinic, University of Alberta, Edmonton, Alberta, Canada

Warren H. Finlay, PhD, Professor, Aerosol Research Laboratory, Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada, T6G 2G8; e-mail: warren.finlay@ualberta.ca

1998 by the American College of Chest Physicians

Chest. 1998;114(6):1676-1680. doi:10.1378/chest.114.6.1676
Text Size: A A A
Published online


Study objectives: To determine the amount of salbutamol or beclomethasone delivered from metered-dose inhalers (MDIs) in particle sizes appropriate for inhalational treatment with four common holding chambers (AeroChamber, OptiChamber, Space Chamber, E-Z Spacer) when used under simulated pediatric tidal breathing conditions.

Design: Five devices of each type were tested with salbutamol (100 µg, Glaxo-Wellcome) and beclomethasone (50 µg, Glaxo-Wellcome) MDIs. Each device was connected to face replicas representative of 7-month-old (infant), 2-year-old (toddler), and 4-year-old (child) children and aerosol inhaled into a cascade impactor (Anderson) using a valve system and simulated tidal breathing patterns representative of children of these ages.

Measurements and results: Amounts of drug inhaled in fine particles varied significantly between devices and ages (p < 0.01), eg, for beclomethasone, from 4 µg (infant, Space Chamber) to 8 µg (toddler, OptiChamber), and for salbutamol, from 18 to 36 µg. The AeroChamber and OptiChamber behaved quite similarly, delivering more drug in the fine particles than the other two devices, and having insignificant variations in these amounts with age (p > 0.05).

Conclusions: Amounts of drug inhaled in fine particles during pediatric tidal breathing from valved holding chambers are dependent on the holding chamber model, the drug used, and the breathing pattern, although dependence on the breathing pattern is relatively small for some of the devices tested.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543